The binding of these antibody-based switches drives immunological synapse formation between SwtichCAR T-cells and tumor cells in a dose-dependent manner in xenograft models of CD19+ and CD20+ hematological malignancies, respectively (154, 155). The gene discussed is CD19; the disease is neoplasm.